pf

ADM Increases COVID-19 Response Donations

Contact Author
Close
Fill out my online form.

ADM has added $800,000 in donations to the over $1 million already committed to COVID-19 relief efforts.

ADM has announced an additional commitment of $800,000 in donations to organizations focused on addressing needs during COVID-19, including food assistance, hunger relief, and local support to hospitals and first responders.

Previously: ADM, Sazerac Partnership to Increase Hand Sanitizer Production.

The $800,000 in total contributions are in addition to more than $1 million previously committed to COVID-19 related relief efforts. The funds will be directed to various local organizations with a direct impact in communities and regions where ADM has a large presence.

Previously: ADM to Release Q1 2020 Financials Before End of April.

In ADM’s global headquarters base, Chicago, the company is focusing on food scarcity issues through partnerships with the Greater Chicago Food Depository, Lawrence Hall, The Bigger Table and The Trotter Project. ADM is also providing funds to support a partnership with Rutgers to advance virus mitigation research and medical support in parts of Europe, Asia Pacific and South America.

The donations were given through ADM Cares. ADM Cares helps sustain and strengthen communities where ADM colleagues work, live and operate by directing funding, volunteerism and industry knowledge to initiatives and organizations that drive meaningful social, economic and environmental progress worldwide. ADM Cares focuses its efforts primarily in three areas: Advancing Sustainable Agriculture; Increasing Food Security; and Investing in Education.

“These are unprecedented times, and ADM is committed to doing our part to help address the tremendous need around the world right now,” said Chairman and CEO Juan Luciano. “We are proud to take part in Giving Tuesday’s efforts to unite companies, individuals and communities around the world to tackle the great challenges brought on by the global fight against COVID-19.”